In addition, it has been showed that the fractalkine receptor CX3CR1 plays a key role in atherosclerosis [305], and that a polymorphism in its gene is associated with a reduced risk for CAD [306]. The gene discussed is CX3CR1; the disease is coronary artery disorder.